Department of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
Endocrinology. 2012 May;153(5):2062-9. doi: 10.1210/en.2011-2117. Epub 2012 Feb 28.
Emerging evidence supports the hypothesis that the skeleton is an endocrine organ that regulates energy metabolism through the release of the osteoblast-derived hormone, osteocalcin (Ocn). This bone-pancreas endocrine network is controversial because important gaps remain to be filled in our knowledge of the physiological effects of Ocn in multiple organs and the complex alterations in other hormonal networks induced by Ocn administration. A key step toward understanding the integrative regulation of energy metabolism by bone is the identification of GPCR family C group 6 member A (GPRC6A) as the Ocn receptor. GPRC6A is an amino acid-sensing G protein-coupled receptor highly expressed in β-cells and is activated by recombinant Ocn in vitro and in vivo but that is widely expressed in tissues other than the pancreas and is capable of sensing multiple structurally unrelated ligands, including l-amino acids, cations, and anabolic steroids in addition to Ocn. The broad expression and multiligand specificity of GPRC6A is identifying both systemic and paracrine regulation of seemingly disparate biological processes, ranging from energy metabolism, sexual reproduction, hypothalamic-pituitary function, bone formation, and prostate cancer. Consistent with the existence of more complex endocrine networks, ablation of GPRC6A in Gprc6a(-/-) mice results in complex metabolic abnormalities, including obesity, glucose intolerance, hepatic steatosis, insulin resistance, hyperphosphatemia, osteopenia, plus several hormonal abnormalities, including decreased circulating testosterone, IGF-I, and insulin and increased estradiol, LH, GH, and leptin. Recombinant Ocn also regulates testosterone production by the testes and male fertility through a GPRC6A-dependent mechanism, and testosterone regulation of LH secretion is abnormal in Gprc6a(-/-) mice. Thus, GPRC6A, as the biologically relevant receptor for Ocn, defines not only a molecular mechanism for linking bone metabolism with metabolic regulation of β-cells and sexual reproduction but also as a receptor shared by testosterone and dietary factors, and it is also involved in multiple endocrine networks integrating the functions of pancreas, muscle, liver, fat, testes, bone, and the hypothalamic-pituitary axis with alterations in both environmental and endogenous ligands.
新出现的证据支持这样一种假说,即骨骼是一种内分泌器官,通过释放成骨细胞衍生的激素骨钙素 (Ocn) 来调节能量代谢。这种骨-胰腺内分泌网络存在争议,因为我们对 Ocn 在多个器官中的生理作用以及 Ocn 给药引起的其他激素网络的复杂改变的了解仍存在重要空白。理解骨骼对能量代谢的整合调节的关键步骤是确定 G 蛋白偶联受体家族 C 组 6 成员 A (GPRC6A) 为 Ocn 受体。GPRC6A 是一种氨基酸感应 G 蛋白偶联受体,在 β 细胞中高度表达,在体外和体内可被重组 Ocn 激活,但它广泛表达于胰腺以外的组织中,并且能够感应多种结构上无关的配体,包括除 Ocn 之外的 l-氨基酸、阳离子和合成代谢类固醇。GPRC6A 的广泛表达和多配体特异性正在确定从能量代谢、生殖、下丘脑-垂体功能、骨形成到前列腺癌等看似不同的生物学过程的全身和旁分泌调节。与更复杂的内分泌网络的存在一致,Gprc6a(-/-) 小鼠中 GPRC6A 的缺失导致复杂的代谢异常,包括肥胖、葡萄糖不耐受、肝脂肪变性、胰岛素抵抗、高磷血症、骨质疏松症以及几种激素异常,包括循环睾酮、IGF-I 和胰岛素减少以及雌二醇、LH、GH 和瘦素增加。重组 Ocn 还通过 GPRC6A 依赖性机制调节睾丸中的睾酮产生和雄性生育能力,并且 Gprc6a(-/-) 小鼠中的 LH 分泌的睾酮调节异常。因此,GPRC6A 作为 Ocn 的生物相关受体,不仅定义了将骨代谢与 β 细胞和生殖的代谢调节联系起来的分子机制,而且还定义了作为睾酮和膳食因素共享的受体,并且它还涉及多个内分泌网络,整合了胰腺、肌肉、肝脏、脂肪、睾丸、骨骼和下丘脑-垂体轴的功能,以及环境和内源性配体的改变。